Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. financial statements

Edgewise Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 167.79M10-K
Cash and equivalentsUSD 61.15M10-Q
Total debtUSD 3.99MEODHD

Edgewise Therapeutics, Inc. financials on 6ix · Edgewise Therapeutics, Inc. on 6ix